The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis
Authors:
- Reza TabriziRTReza Tabrizi
- Kamran B LankaraniKLKamran B Lankarani
- Peyman Nowrouzi-SohrabiPNPeyman Nowrouzi-Sohrabi
- Mojtaba Shabani-BorujeniMSMojtaba Shabani-Borujeni
- Shahla RezaeiSRShahla Rezaei
- Mahnaz Hosseini-BensenjanMHMahnaz Hosseini-Bensenjan
- Seyed Taghi HeydariSHSeyed Taghi Heydari
- Mohammad Ali AshrafMAMohammad Ali Ashraf
Preprint
Abstract
Background: COVID_19 is unpredictable due to non-specific symptoms and clinical course diversity in different individuals. We analyzed studies regarding the factors associated with severe status of the disease to identify unique findings in severely affected patients. Methods: We systematically searched the electronic databases, including PubMed, Scopus, EMBASE, Web of Science, and Google Scholar from inception to 12 th of March 2020. Cochrane’s Q and I-square statistics were used to assess the existence of heterogeneity between the included studies. We used the random-effects model to pool the odds ratios (ORs) at 95% confidence intervals (CIs). Results: Seventeen articles out of 3009 citations were included. These contained 3189 patients, of whom 732 were severely affected (severe group) and 3189 were in non-severe group. Using the random-effects model, our meta-analyses showed that the odds of comorbidities, including COPD, DM, HTN, CVD, CKD, and symptoms, including dyspnea, dizziness, anorexia, and cough, were significantly higher among the severe group compared with the non-severe group. There were no significant changes in odds of CVA, liver disease, immunodeficiency/immunosuppression, fever, fatigue, myalgia, headache, diarrhea, sore throat, nasal congestion, sputum, nausea, vomiting, chest pain between the two groups. Conclusions: Early recognition and intervention can be critical in management, and might stop progression to severe disease. Predictive symptoms and comorbidities can be used as a predictor in patients who are at risk of severe disease.Keywords
This publication has 30 references indexed in Scilit:
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19New England Journal of Medicine, 2020
- COVID-19 and Italy: what next?The Lancet, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Full spectrum of COVID-19 severity still being depictedThe Lancet, 2020
- Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, HubeimedRxiv, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Clinical characteristics of 2019 novel coronavirus infection in ChinamedRxiv, 2020
- Clinical Features and Short-Term Outcomes of 114 Elderly Patients with COVID-19 in Wuhan, China: A Single-Center, Retrospective, Observational StudySSRN Electronic Journal, 2020
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaNew England Journal of Medicine, 2012
- A Novel Coronavirus Associated with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003